AAAAAA

   
Results: 1-14 |
Results: 14

Authors: TAKAMURA N SHINOZAWA S MARUYAMA T SUENAGA A OTAGIRI M
Citation: N. Takamura et al., EFFECTS OF FATTY-ACIDS ON SERUM BINDING BETWEEN FUROSEMIDE AND VALPROIC ACID, Biological & pharmaceutical bulletin, 21(2), 1998, pp. 174-176

Authors: NARAZAKI R WATANABE H MARUYAMA T SUENAGA A OTAGIRI M
Citation: R. Narazaki et al., AN IMMUNOLOGICAL METHOD FOR THE DETECTION OF CAPTOPRIL-PROTEIN CONJUGATE, Archives of toxicology, 72(4), 1998, pp. 203-206

Authors: MOMOEDA M TSUTSUMI O MORITA Y IGARASHI T SUENAGA A OSUGA Y SHIOTSU H YANO T TAKETANI Y
Citation: M. Momoeda et al., DIFFERENTIAL EFFECT OF EXOGENOUS HUMAN CHORIONIC-GONADOTROPIN ON PROGESTERONE PRODUCTION FROM NORMAL OR MALFUNCTIONING CORPUS-LUTEUM, Human reproduction (Oxford. Print), 13(7), 1998, pp. 1907-1911

Authors: SUENAGA A KOMEIJI Y UEBAYASI M MEGURO T SAITO M YAMATO I
Citation: A. Suenaga et al., COMPUTATIONAL OBSERVATION OF AN ION PERMEATION THROUGH A CHANNEL PROTEIN, Bioscience reports, 18(1), 1998, pp. 39-48

Authors: TAKAMURA N MARUYAMA T AHMED S SUENAGA A OTAGIRI M
Citation: N. Takamura et al., INTERACTIONS OF ALDOSTERONE ANTAGONIST DIURETICS WITH HUMAN SERUM-PROTEINS, Pharmaceutical research, 14(4), 1997, pp. 522-526

Authors: SHIRABE S NAKAMURA T TSUJINO A NISHIURA Y FURUYA T GOTO H SUENAGA A NAKANE S YOSHIMURA T NAGATAKI S
Citation: S. Shirabe et al., SUCCESSFUL APPLICATION OF PENTOXIFYLLINE IN THE TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY, Journal of the neurological sciences, 151(1), 1997, pp. 97-101

Authors: TAKAHASHI Y MIYAJIMA H SHIRABE S NAGATAKI S SUENAGA A GITLIN JD
Citation: Y. Takahashi et al., CHARACTERIZATION OF A NONSENSE MUTATION IN THE CERULOPLASMIN GENE RESULTING IN DIABETES AND NEURODEGENERATIVE DISEASE, Human molecular genetics, 5(1), 1996, pp. 81-84

Authors: TAKAMURA N HARUTA A KODAMA H TSURUOKA M YAMASAKI K SUENAGA A OTAGIRI M
Citation: N. Takamura et al., MODE OF INTERACTION OF LOOP DIURETICS WITH HUMAN SERUM-ALBUMIN AND CHARACTERIZATION OF BINDING-SITE, Pharmaceutical research, 13(7), 1996, pp. 1015-1019

Authors: SUENAGA A SHIRABE S NAKAMURA T MOTOMURA M TSUJIHATA M MATSUO H KATAOKA Y NIWA M ITOH M NAKATAKI S
Citation: A. Suenaga et al., SPECIFICITY OF AUTOANTIBODIES REACT WITH OMEGA-CONOTOXIN MVIIC-SENSITIVE CALCIUM-CHANNEL IN LAMBERT-EATON MYASTHENIC SYNDROME, Muscle & nerve, 19(9), 1996, pp. 1166-1168

Authors: SUENAGA A TACHI C TOJO H TANAKA S TSUTSUMI O TAKETANI Y
Citation: A. Suenaga et al., QUANTITATIVE-ANALYSIS OF THE SPREADING OF THE MOUSE TROPHOBLAST IN-VITRO - A MODEL FOR EARLY INVASION, Placenta, 17(8), 1996, pp. 583-590

Authors: NAKAMURA T SHIRABE S ICHINOSE K NISHIURA Y WATANABE H SUENAGA A YOSHIMURA T TSUJIHATA M NAGATAKI S
Citation: T. Nakamura et al., PENTOXIFYLLINE TREATMENT IN HTLV-I-ASSOCIATED MYELOPATHY, Internal medicine, 34(5), 1995, pp. 460-460

Authors: TAKAMORI M TAKAHASHI M YASUKAWA Y IWASA K NEMOTO Y SUENAGA A NAGATAKI S NAKAMURA T
Citation: M. Takamori et al., ANTIBODIES TO RECOMBINANT SYNAPTOTAGMIN AND CALCIUM-CHANNEL SUBTYPES IN LAMBERT-EATON MYASTHENIC SYNDROME, Journal of the neurological sciences, 133(1-2), 1995, pp. 95-101

Authors: MATSUI M ENOKI M MATSUI Y OONO S OHTA M SUENAGA A KURODA Y
Citation: M. Matsui et al., SERONEGATIVE MYASTHENIA-GRAVIS ASSOCIATED WITH ATONIC URINARY-BLADDERAND ACCOMMODATIVE INSUFFICIENCY, Journal of the neurological sciences, 133(1-2), 1995, pp. 197-199

Authors: OHTSURU I MATSUO H FUKUDOME T SUENAGA A TSUJIHATA M NAGATAKI S
Citation: I. Ohtsuru et al., SPLIT TOLERANCE INDUCTION BY INTRATHYMIC INJECTION OF ACETYLCHOLINE-RECEPTOR IN A RAT MODEL OF AUTOIMMUNE MYASTHENIA-GRAVIS - IMPLICATIONS FOR THE DESIGN OF SPECIFIC IMMUNOTHERAPIES, Clinical and experimental immunology, 102(3), 1995, pp. 462-467
Risultati: 1-14 |